Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
What will members gain?

Download Now: New Slide Deck Programme

Previous slide decks focused on landmark studies which used a monoclonal antibody approach to inhibit PCSK9. The next in this series discusses inclisiran, a small interfering RNA therapy, which prevents production of PCSK9 at its primary source in the liver.

Find out more »

Hot Topics

News from the 11th Expert Meeting of the Editorial Board of PCSK9 Forum

LDL transcytosis in atherosclerosis: Professor Phil Shaul (Center for Pulmonary and Vascular Biology, University of Texas Southwestern Medical Center, Dallas, USA)


View the Webcast


Emerging lipid science – Apolipoprotein E and chronic disease: Professor Ruth Frikke-Schmidt (Rigshospitalet and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark) discusses exciting research

View the Webcast

From the Editors

Monogenic versus polygenic familial hypercholesterolaemia: how does cardiovascular risk compare?

Does cardiovascular risk differ between individuals with monogenic hypercholesterolaemia or polygenic hypercholesterolaemia?
Prof. Derick Raal, University of the Witwatersrand, Johannesburg, South Africa, discusses a new report

Read the report


Other related reports:
Stratifying risk in familial hypercholesterolaemia: does coronary artery calcium have a role?
Read the report
A new genetic mechanism for familial hypercholesterolaemia: PCSK9 whole gene duplication
Read the report
Study reinforces the importance of cascade screening in families with familial hypercholesterolaemia
Read the report
Start treatment early: Maximise benefit
Read the report

ACC 2017

Meet our Editorial Board

View all our Editorial Board Prof John ChapmanResearch Professor at the University of Pierre and Marie Curie Prof Henry GinsbergDirector, Irving Institute for Clinical and Translational Research Dr Michel FarnierClinician based at Point Medical, Dijon, France Prof Frederick RaalDirector, Carbohydrate & Lipid Metabolism Research Unit Prof Anthony WierzbickiConsultant in Metabolic Medicine/Chemical Pathology